๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Novozyme records higher sales for 1H 2002

Publisher
Elsevier Science
Year
2002
Weight
33 KB
Volume
2002
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

โœฆ Synopsis

under a new contract to an advanced drug ingredient producer. The company is scaling up to the tens of tons level. JEP broke even for the first time in 2001.

๐Ÿ“œ SIMILAR VOLUMES

Strong sales and margin growth for Novoz
Strong sales and margin growth for Novozymes in 1Q 2006
๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Elsevier Science โš– 50 KB

also rejected the latest offer of $38 per share. BASF is "considering all its options." Engelhard is also to increase the size of its board from six to nine members.